BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24674108)

  • 1. Intentional overdose of warfarin in an adult: anticoagulant reversal in the ED.
    Matthews SS; Ringeisen AL; Wedro B
    Am J Emerg Med; 2014 Sep; 32(9):1150.e1-2. PubMed ID: 24674108
    [No Abstract]   [Full Text] [Related]  

  • 2. Phytonadione therapy in a multiple-drug overdose involving warfarin.
    Bates D; Mintz M
    Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrhagic complications during warfarin treatment].
    Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
    Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin-associated intracerebral hemorrhage is inadequately treated at community emergency departments.
    Liotta EM; Garg RK; Temes RE; John S; Lee VH; Bleck TP; Prabhakaran S
    Stroke; 2012 Sep; 43(9):2503-5. PubMed ID: 22773555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
    Nishijima DK; Dager WE; Schrot RJ; Holmes JF
    Acad Emerg Med; 2010 Mar; 17(3):244-51. PubMed ID: 20370756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII as a temporary reversal agent for warfarin anticoagulation: a cautionary report on an off-label application.
    Kalainov DM; Valentino LA
    Am J Orthop (Belle Mead NJ); 2008 Nov; 37(11):572-4. PubMed ID: 19104685
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage.
    Rowe AS; Turner RM
    Am J Health Syst Pharm; 2010 Mar; 67(5):361-5. PubMed ID: 20172985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NovoSeven in warfarin-treated patients.
    Berntorp E; Stigendal L; Lethagen S; Olofsson L; Hedner U
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S113-5. PubMed ID: 10850575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008.
    Rosovsky RP; Crowther MA
    Hematology Am Soc Hematol Educ Program; 2008; ():36-8. PubMed ID: 19074054
    [No Abstract]   [Full Text] [Related]  

  • 12. Controversies of anticoagulation reversal in life-threatening bleeds.
    Rolfe S; Papadopoulos S; Cabral KP
    J Pharm Pract; 2010 Jun; 23(3):217-25. PubMed ID: 21507817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of a potent investigational anticoagulant: idraparinux with recombinant factor VIIa.
    Dao A; Tuan B; Carlson N
    Am J Med; 2005 Oct; 118(10):1172-3. PubMed ID: 16194652
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries for patients. A new way to reverse excessive blood thinning from warfarin.
    Ann Intern Med; 2002 Dec; 137(11):I41. PubMed ID: 12459002
    [No Abstract]   [Full Text] [Related]  

  • 15. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 16. Intentional overdose of warfarin in an adolescent: need for follow up.
    Ramanan AV; Gissen P; Bose-Haider B
    Emerg Med J; 2002 Jan; 19(1):90. PubMed ID: 11777896
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant factor VIIa for warfarin-associated intracranial bleeding.
    Ilyas C; Beyer GM; Dutton RP; Scalea TM; Hess JR
    J Clin Anesth; 2008 Jun; 20(4):276-9. PubMed ID: 18617125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin overdose: a 25-year experience.
    Levine M; Pizon AF; Padilla-Jones A; Ruha AM
    J Med Toxicol; 2014 Jun; 10(2):156-64. PubMed ID: 24488527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid warfarin reversal with factor VIIa in an elderly trauma patient with retroperitoneal hematoma.
    Testerman GM; Shilad S; George KJ
    Tenn Med; 2009 Mar; 102(3):37-9. PubMed ID: 19354059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin and intracranial haemorrhage.
    Appelboam R; Thomas EO
    Blood Rev; 2009 Jan; 23(1):1-9. PubMed ID: 18583002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.